Physician profile
Rex Berry
NPI 1124787098
$3,628.53
in general payments reported to CMS, 2019-2025
17 companies · $877 in 2025
The $877 reported for 2025 was more than what 78% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $162 · 2023: $464 · 2024: $2,125 · 2025: $877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,670 · Travel and Lodging: $707 · Education: $89.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,670.42 |
| Travel and Lodging | $706.91 |
| Education | $89.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,125.41 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $887.04 | 2022-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $408.19 | 2022-2025 | Trelegy Ellipta, Nucala |
| Regeneron Healthcare Solutions, INC. | $304.02 | 2022-2025 | Dupixent |
| Verona Pharma, INC. | $184.20 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.52 | 2022-2024 | Ofev, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $114.69 | 2022-2024 | |
| Grifols USA, LLC | $111.75 | 2022-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $94.58 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Takeda Pharmaceuticals U.S.A., INC. | $70.20 | 2023-2024 | Glassia |
| United Therapeutics Corporation | $46.82 | 2022-2025 | Tyvaso |
| Vifor Pharma, INC. | $42.30 | 2024-2025 | Zemaira |
| Mylan Specialty L.P. | $34.30 | 2024 | Yupelri |
| Axsome Therapeutics, INC. | $22.77 | 2024 | Sunosi |
| Philips North America LLC | $22.49 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $17.26 | 2023 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Baxter Healthcare | $14.99 | 2023 | Hillrom - Life 2000 Ventilation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.